ERBB2 and neoplasm: Next, using mRNA expression data from 34 primary patient tumor samples for which hormone receptor and HER2 expression data were available, we found that VEGF-A and NRP1 mRNA expression levels were significantly elevated in triple-negative tumors compared with hormone receptor-positive or HER2-positive tumors (Fig. 7B).